These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26378761)

  • 21. Cutaneous manifestations of metastatic Crohn's disease.
    Schneider SL; Foster K; Patel D; Shwayder T
    Pediatr Dermatol; 2018 Sep; 35(5):566-574. PubMed ID: 29952016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous manifestations of gastrointestinal disease: part II.
    Thrash B; Patel M; Shah KR; Boland CR; Menter A
    J Am Acad Dermatol; 2013 Feb; 68(2):211.e1-33; quiz 244-6. PubMed ID: 23317981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extraintestinal manifestations in chronic inflammatory bowel diseases].
    Vavricka SR; Greuter T; Zeitz J
    Ther Umsch; 2019 Jan; 75(5):281-285. PubMed ID: 30700241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.
    Pagani K; Lukac D; Bhukhan A; McGee JS
    Am J Clin Dermatol; 2022 Jul; 23(4):481-497. PubMed ID: 35441942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermatological signs during inflammatory bowel diseases.
    Feliciani C; De Simone C; Amerio P
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():15-21. PubMed ID: 19530507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dermatologic Manifestations in Inflammatory Bowel Disease].
    Suh HY; Lee WJ; Na SY
    Korean J Gastroenterol; 2019 May; 73(5):285-293. PubMed ID: 31132835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study.
    Moravvej H; Razavi GM; Farshchian M; Malekzadeh R
    Indian J Dermatol Venereol Leprol; 2008; 74(6):607-10. PubMed ID: 19171983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-related and drug-induced skin manifestations in inflammatory bowel disease.
    Hindryckx P; Novak G; Costanzo A; Danese S
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):203-214. PubMed ID: 28095714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyoderma Gangrenosum and inflammatory bowel disease: a combined medical and surgical approach - case report and literature review.
    Garieri P; Marcasciano M; Greto Ciriaco A; Spagnuolo R; Vitagliano T; Kaciulyte J; Casella D; Lo Torto F; Parisi P; Ribuffo D; Greco M
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5191-5199. PubMed ID: 35916817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
    Apgar JT
    Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophilic dermatoses and inflammatory bowel diseases.
    Marzano AV; Menicanti C; Crosti C; Trevisan V
    G Ital Dermatol Venereol; 2013 Apr; 148(2):185-96. PubMed ID: 23588144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dermatological Manifestations in Pediatric Inflammatory Bowel Disease.
    Diaconescu S; Strat S; Balan GG; Anton C; Stefanescu G; Ioniuc I; Stanescu AMA
    Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32842528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease?
    Satta R; Pes GM; Rocchi C; Pes MC; Dore MP
    J Dermatolog Treat; 2019 Sep; 30(6):612-616. PubMed ID: 30244616
    [No Abstract]   [Full Text] [Related]  

  • 34. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
    Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
    Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.
    Severs M; van Erp SJ; van der Valk ME; Mangen MJ; Fidder HH; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Bolwerk C; Vermeijden JR; Pierik MJ; Siersema PD; Leenders M; van der Meulen-de Jong AE; Dijkstra G; Oldenburg B;
    J Crohns Colitis; 2016 Apr; 10(4):455-61. PubMed ID: 26721937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic Crohn's disease of the umbilicus.
    McLelland J; Griffin SM
    Clin Exp Dermatol; 1996 Jul; 21(4):318-9. PubMed ID: 8959912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Important cutaneous manifestations of inflammatory bowel disease.
    Trost LB; McDonnell JK
    Postgrad Med J; 2005 Sep; 81(959):580-5. PubMed ID: 16143688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peristomal cutaneous Crohn's disease by contiguity.
    Palomar Ávila C; Moreno Pimentel C; Masero Carretero JM; Coca López M
    Rev Esp Enferm Dig; 2023 Aug; 115(8):454-455. PubMed ID: 35791785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexistent pyoderma gangrenosum and tibialis anterior myositis as presenting manifestations of Crohn's disease: case report and review of the literature.
    Goldshmid O; Dovorish Z; Zehavi T; Eisen A; Bar-Dayan Y; Amital H
    Rheumatol Int; 2011 Apr; 31(4):525-7. PubMed ID: 19847433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
    Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
    Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.